Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Graft Vs. Host Disease Pipeline Highlights to 2019 - H2 2016 Update - Research and Markets

Research and Markets
Posted on: 01 Dec 16

Research and Markets has announced the addition of the "Graft Vs. Host Disease Pipeline Highlights - 2016 Update" drug pipelines to their offering.

Graft Vs. Host Disease Pipeline Highlights - 2016 Update, provides most up-to-date information on key pipeline products in the global Graft Vs. Host Disease market. It covers emerging therapies for Graft Vs. Host Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Scope of the Report

Clinical Trial Stages:

The report provides Graft Vs. Host Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Graft Vs. Host Disease pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Graft Vs. Host Disease pipeline products by the company.

Short-term Launch Highlights:

Find out which Graft Vs. Host Disease pipeline products will be launched in the US and Ex-US till 2019.

Key Topics Covered:

1. Graft Vs. Host Disease Pipeline by Stages

2. Graft Vs. Host Disease Pipeline by Drug Class

3. Graft Vs. Host Disease Pipeline by Company

4. Graft Vs. Host Disease Phase 3 Clinical Trial Insights

5. Graft Vs. Host Disease Phase 2 Clinical Trial Insights

6. Graft Vs. Host Disease Phase 1 Clinical Trial Insights

7. Graft Vs. Host Disease Preclinical Research Insights

8. Graft Vs. Host Disease Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/5ttt5r/graft_vs_host

View source version on businesswire.com: http://www.businesswire.com/news/home/20161201005627/en/

Business Wire
www.businesswire.com

Last updated on: 01/12/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.